
Sign up to save your podcasts
Or


Co-Medical Director of the Melanoma Institute Australia, Professor Richard Scolyer AO is a world-leading clinician and researcher who has spent years alongside his colleagues transforming melanoma treatment, Australia’s deadliest cancer. At the peak of his career, his world was turned upside down when he was diagnosed with an incurable Grade 4 glioblastoma.
Refusing to accept the status quo—where treatment options had remained unchanged for nearly two decades—he made the courageous decision to become “patient zero” in a world-first experimental immunotherapy.
Moderated by Jamila Rizvi, this fascinating conversation follows Richard’s remarkable journey and celebrates the publication of his latest book Brainstorm.
This event was recorded live at Sydney Opera House on 17 November 2024
Hosted on Acast. See acast.com/privacy for more information.
By Sydney Opera House4.9
2222 ratings
Co-Medical Director of the Melanoma Institute Australia, Professor Richard Scolyer AO is a world-leading clinician and researcher who has spent years alongside his colleagues transforming melanoma treatment, Australia’s deadliest cancer. At the peak of his career, his world was turned upside down when he was diagnosed with an incurable Grade 4 glioblastoma.
Refusing to accept the status quo—where treatment options had remained unchanged for nearly two decades—he made the courageous decision to become “patient zero” in a world-first experimental immunotherapy.
Moderated by Jamila Rizvi, this fascinating conversation follows Richard’s remarkable journey and celebrates the publication of his latest book Brainstorm.
This event was recorded live at Sydney Opera House on 17 November 2024
Hosted on Acast. See acast.com/privacy for more information.

109 Listeners

847 Listeners

786 Listeners

10 Listeners

138 Listeners

71 Listeners

19 Listeners

217 Listeners

338 Listeners

61 Listeners

122 Listeners

88 Listeners

410 Listeners

171 Listeners

59 Listeners

110 Listeners